3/18/2008 10:03:48 AM
BETHLEHEM, Pa.--(BUSINESS WIRE)--GlucoLight Corporation, a development-stage company focused on non-invasive, continuous blood glucose monitoring, today announced the closing of the third tranche of its “C” round financing. The amount of the third tranche was not disclosed. In addition to the second tranche of financing announced in February, GlucoLight is nearing the close of its “C” round.
comments powered by